Abstract:
An organic light-emitting device (OLED) is disclosed. The OLED includes a pixel electrode; a counter electrode; and at least an emission layer between the pixel electrode and the counter electrode, wherein a total thickness of the organic layer including an emission layer emitting blue light is 3000-3600 Å. According to the OLED of the present disclosure, the incidence of dark spots can be remarkably reduced without degradation of color purity and efficiency, and thus the flat display including the OLED has improved reliability.
Abstract:
An electroluminescence (EL) display device can include a display area with pixels (each of which can include a first electrode layer and a second electrode layer on a substrate and electroluminescence units formed between the first and second electrode layers), an electrode power supply line supplying electrode power to the display area, one or more insulating layers disposed on the electrode power supply line (including one or more via holes and containing an organic material), and a sub-conductive layer formed on the insulating layer including the via hole along the electrode power supply line. In addition, the electrode power supply line and the second electrode layer may be coupled to each other at the via hole through the sub-conductive layer. The sub-conductive layer on the insulating layer can include one or more penetration portions.
Abstract:
The subject invention is directed to a mixed cell composition to generate a therapeutic protein at a target site by providing a first population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene, wherein endogenously existing forms of the second population of mammalian cells are decreased at the target site, and wherein generation of the therapeutic protein by the first population of mammalian cells at the target site stimulates the second population cells to induce a therapeutic effect.
Abstract:
An organic light emitting display (OLED) and method of fabricating the same are provided having a reduced number of photolithography and etching steps. The method includes a source electrode and a drain electrode being formed over a substrate, and at least one insulating layer being formed over the source electrode and drain electrode. After the insulation layer is formed, a reflecting layer pattern is formed. A via contact hole is formed through the insulating layer using the reflecting layer pattern as an etching mask. Multiple insulating layers may be formed and have a via contact hole etched therethrough in one etching step using the reflecting layer pattern as a mask. Alternatively, each insulating layer may have a via contact hole separately etched therethrough, with the last layer being etched using the reflective layer pattern as a mask. Consequently, the number of photolithography and etching steps is reduced thereby leading to higher manufacturing yield and lower manufacturing cost.
Abstract:
A cutting insert for a milling machining adapted to be mounted on a milling cutter to carry out cutting operation and having primary and secondary cutting edges provided at sides of a rectangular body, each primary cutting edge having a curved line tangential to the adjacent secondary cutting edge, to reduce the cutting force and improve flatness of the side surface of a machined workpiece. The cutting insert includes an upper face, a bottom face and a plurality of side faces connecting the upper face and the bottom face. The primary cutting edge has chip breakers for guiding chip flow, primary cutting edge land faces and primary cutting edge clearance faces. The primary cutting edges enable a bottom surface and a side surface of a machined workpiece to have a right angle therebetween.
Abstract:
An organic light-emitting display device and a method of fabricating the device are disclosed. The organic light-emitting display device includes a thin-film transistor positioned on a substrate that has a semiconductor layer, a gate electrode, and source and drain electrodes. A first electrode is positioned, which is connected to either the source electrode or drain electrode. A reflective layer, which is spaced apart from the source electrode or drain electrode, is positioned below the first electrode. An organic functional layer having at least an emission layer is positioned on the first electrode. A second electrode is positioned on the organic functional layer. The first electrode, the reflective layer, the organic functional layer, and the second electrode constitute an organic light-emitting diode.
Abstract:
The subject invention is related to a cell-mediated gene therapy treatment for orthopedic disease using a member belonging to the transforming growth factory-&bgr; (TGF-&bgr;) superfamily. TGF-&bgr; gene therapy as a new treatment method for degenerative arthritis is demonstrated. After transfection of TGF-&bgr; cDNA expression vectors into fibroblasts (NIH 3T3-TGF-&bgr;1), the cells were injected into rabbit achilles tendon and knee joints with artificially-made cartilage defects. Intratendinous injections were performed to determine the optimal concentration for in vivo expression. Partially defected cartilage model was made to simulate degenerative arthritis of the knee joint. The partial cartilage defect treated with the cell-mediated gene therapy procedure was covered by newly formed hyaline cartilage which indicates that the cells survived and stimulated matrix formation in this area. Completely denuded cartilage areas were covered by fibrous collagen.
Abstract:
This invention is about the identification of the HD-2, a natural chemical substance that was separated and purified from a natural product, Sinsuk, as arsenic hexoxide (As4O6) and about its therapeutic efficacy as an anti-cancer drug and pharmaceutical composition. Arsenic hexoxide (As4O6), a natural chemical substance obtained from Sinsuk after eliminating the toxic property, has a potent anti-cancer efficacy by its direct cytotoxicity on tumor cells and suppresses the formation of new blood vessels of tumor masses, which results in complete cure of malignant cancers.
Abstract translation:本发明涉及从天然产物Sinsuk分离和纯化的作为六氧化二砷(As 4 O 6)的天然化学物质及其作为抗癌药物和药物组合物的疗效的HD-2的鉴定。 六氧化二锑(As4O6)是消除毒性后从辛辛苏获得的天然化学物质,通过其对肿瘤细胞的直接细胞毒性具有有效的抗癌功能,抑制了肿瘤块的新血管的形成,导致完全固化 恶性肿瘤